ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial Marc Waldman brings over 35 years of commercial leadership experience in the medical device industry with a proven track record of driving top-line growth GlobeNewswire January 21, 2026 TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) — ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” […]

Live Ventures Deploys AI Engine to Forecast Demand, Cut Costs, and Accelerate Retail Margins

Live Ventures Deploys AI Engine to Forecast Demand, Cut Costs, and Accelerate Retail Margins GlobeNewswire January 21, 2026 LAS VEGAS and FAIRFIELD, Calif., Jan. 21, 2026 (GLOBE NEWSWIRE) — Live Ventures Incorporated (Nasdaq: LIVE) (“Live Ventures”), a diversified holding company, today announced that its Flooring Liquidators, Inc. (“Flooring Liquidators”) subsidiary has deployed artificial intelligence as

Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit

Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit GlobeNewswire January 21, 2026 Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced that Company management, including CEO Ilan Hadar, will attend the 7th RNAi-Based Therapeutics Summit, taking place January 27-29

Deal Engine Ushers In a New Data Engine Category for Private Equity

Deal Engine Ushers In a New Data Engine Category for Private Equity Rebranding from Filament Syfter, the firm's new name and identity reflect its role in enabling every firm to unify their proprietary internal data and external market data into a single source of firm-wide market intelligence GlobeNewswire January 21, 2026 NEW YORK and LONDON,

Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook

Entera Bio Announces Upcoming Q1 2026 Corporate Priorities and Pipeline Outlook GlobeNewswire January 21, 2026 Final EB613 Phase 3 Protocol Submission to FDA Planned for Q1 2026, Following December 19th 2025 FDA Ruling Next-Generation EB613 Phase 1 Bridging Study Progressing with Results Expected During Q1 2026 Oral Hypoparathyroidism Tablet Program to Accelerate with Lead Long-Acting

Genetec named one of Canada’s Top Employers for Young People for the third consecutive year

Genetec named one of Canada's Top Employers for Young People for the third consecutive year Recognition highlights learning, mentorship, and strong connections with local universities GlobeNewswire January 21, 2026 MONTRÉAL, Jan. 21, 2026 (GLOBE NEWSWIRE) — Genetec Inc. (“Genetec”), the global leader in enterprise physical security software, today announced that it has been named one

Verisk to Announce Fiscal Fourth-Quarter 2025 and Full-Year 2025 Results on February 18, 2026

Verisk to Announce Fiscal Fourth-Quarter 2025 and Full-Year 2025 Results on February 18, 2026 GlobeNewswire January 21, 2026 JERSEY CITY, N.J., Jan. 21, 2026 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, will report its financial results for the fourth quarter and fiscal year

Mars Honored by Glassdoor as One of the Best Places to Work in the U.S.

Mars ranked #1 and #6 on two of Glassdoor’s annual Employees’ Choice Awards lists, earning the distinctions based on employee feedback — Mars earned the top spot on Glassdoor’s Inaugural Best Places to Work in Manufacturing and Energy list. — The company has also ranked number six on Glassdoor’s 2026 Best Places to Work list.

The Value of a Systems of Systems Approach with Digital Twins

BOSTON, MA, Jan. 21, 2026 (GLOBE NEWSWIRE) — The Digital Twin Consortium(R) (DTC) today announced a new white paper, “The Value of a Systems of Systems Approach with Digital Twins: A Case Study of Airport Passenger Boarding Bridges.” The paper presents a practical blueprint for airport operators to enhance gate reliability, reduce emissions, and advance

AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast

AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast “According to BCC Research, AI is speeding up clinical development with smarter recruitment, better analytics, and real-time decision support across global trials.” GlobeNewswire January 21, 2026 Boston, Jan. 21, 2026 (GLOBE NEWSWIRE) — Artificial intelligence (AI) is rapidly transforming how clinical trials

Scroll to Top